MINNEAPOLIS, MN – December 19, 2018 – Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a
medical technology company focused on the development and commercialization of innovative and
minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that its
management team will be presenting at the 37th Annual J.P. Morgan Healthcare Conference on January
10, 2019 at the Westin St. Francis Hotel in San Francisco.
Inspire is scheduled to present at 9:00am Pacific Time. The presentation will be accessible via a live
webcast at: https://jpmorgan.metameetings.net/events/healthcare19/sessions/25739-inspire-medical-
A webcast replay of the presentation will be available for two weeks following the presentation in the
Event Archive section of Inspire’s Investor website at www.investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of
innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s
proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides
a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact: